Underdog Pharmaceuticals CEO and leadership

Michael Kope is Co-Founder and Co-CEO of Underdog Pharmaceuticals, a company whose mission is to treat the underlying causes of age-related disease. Underdog Pharmaceuticals develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. Mr. Kope was also Founding CEO of SENS Research Foundation, a non-profit that is redefining the way the world researches and treats age-related ill health, while inspiring the next generation of biomedical scientists. Mr. Kope received his J.D. from the University of Michigan in 1990. He has served as the University of Michigan’s Intellectual Property Counsel; as Director of Corporate Development for Aviron, and for MedImmune, Inc.; and as CEO and officer of a number of start-ups in the biotechnology space. He specializes in business development and consulting, and is widely experienced with biotechnology organizations. Mike has negotiated a broad range of business acquisition and partnership agreements, designed strategies for technology protection and promotion in many fields of research, and facilitated a number of successful startups.

My passion is performing translational research aimed toward bringing true regenerative medicine to the diseases and disabilities of aging.Specialties: Mitochondria, telomeres, aging research, gene therapy.

Michael Kope is Co-Founder and Co-CEO of Underdog Pharmaceuticals, a company whose mission is to treat the underlying causes of age-related disease. Underdog Pharmaceuticals develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. Mr. Kope was also Founding CEO of SENS Research Foundation, a non-profit that is redefining the way the world researches and treats age-related ill health, while inspiring the next generation of biomedical scientists. Mr. Kope received his J.D. from the University of Michigan in 1990. He has served as the University of Michigan’s Intellectual Property Counsel; as Director of Corporate Development for Aviron, and for MedImmune, Inc.; and as CEO and officer of a number of start-ups in the biotechnology space. He specializes in business development and consulting, and is widely experienced with biotechnology organizations. Mike has negotiated a broad range of business acquisition and partnership agreements, designed strategies for technology protection and promotion in many fields of research, and facilitated a number of successful startups.

My passion is performing translational research aimed toward bringing true regenerative medicine to the diseases and disabilities of aging.Specialties: Mitochondria, telomeres, aging research, gene therapy.